Striking the Optimal Balance in

Similar documents
Strategies to assess and manage hypervolemia The invisible threat in dialysis

FLUID MANAGEMENT IN DIALYSIS: STRATEGIES FOR SUCCESS

Understanding Kt/V and Volume Control

Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University

How to deal with hypotension on dialysis? CME Basics in Nephrology SGN-SSN Interlaken 2016

02/28/2018. To reduce morbidity, mortality and treatment loss associated with chronic volume overload in hemodialysis patients

Achieve. Achieve. More Effective. Dialysis Treatment

Sodium elimination and dialysate sodium. How much? Does it matter?

Challenges to Manage Blood Pressure in ESRD and Heart Failure Patients

Innovations in Cardio/Renal Patient Care. Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018

UNIVERSITY OF CALGARY. Blood Volume Monitoring Guided Ultrafiltration Biofeedback on the Reduction of

RJ Picciano BA, CHT, OCDT, CHBT Fluid Management Coordinator Centers for Dialysis Care, Cleveland Ohio BONENT President

Low Blood Pressure During Dialysis (Intradialytic Hypotension (IDH))

Achieving Equilibrium in ESRD Patients

THE INTRADIALYTIC BIOFEEDBACKS AND THE CARDIOVASCULAR STABILITY IN HYPOTENSION- PRONE PATIENTS Antonio Santoro, Bologna, Italy

Haemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health

Volume control in maintenance hemodialysis: how to keep your patient dry? Dr. Luc Radermacher

LITERA VALLEY ZEE SCHOOL, HOSUR

Ana Paula Bernardo. CHP Hospital de Santo António ICBAS/ Universidade do Porto

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Dialysis induced cardiac and brain injury

Objectives. Peritoneal Dialysis vs. Hemodialysis 02/27/2018. Peritoneal Dialysis Prescription and Adequacy Monitoring

Effect of Dialysis Day on Intradialytic Hypotension Risk

Crit-Line Monitor. Frequently Asked Questions

Dialysis outcomes: can we do better?

How is the dialysis patient different?

DEFINITIONS FOR FLUID STATUS & TARGET WEIGHT

There are no shortcuts to Dialysis

Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality

Plasma sodium as a predictor of death and non-osmotic sodium storage

DIALYSIS THE VIEW FROM THE OTHER SIDE

Saturday 8/26/2017 7:00am - 7:00pm Closed 11:00am - 9:00pm Closed Closed

Physical Activity and Diabetes Appendix

The evaluation of relationship between blood pressure and dialysate Na concentration in chronic hemodialysis patients

Dialysis in frail and Elderly

Patients and Machines. NANT Annual National Symposium Wednesday March 9 th, 2011

HTA ET DIALYSE DR ALAIN GUERIN

KDIGO LESSONS LEARNED FROM NEPHROLOGY TRIALS WITH RESPECT TO HEART FAILURE

Arches National Park, Utah. hospitalization

Effects of Kidney Disease on Cardiovascular Morbidity and Mortality

Hypertension Management Controversies in the Elderly Patient

Thanks to our speaker!

Blood Pressure Measurement in SPRINT

Hemocontrol. Management of Intradialytic Hypotension

On Referral to our Unit

Volume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients

ADVANCES IN MANAGEMENT OF HYPERTENSION

Assessment and Management of Hypertension in Patients on Dialysis

Fall 2018: Spring 2019:

2016 Annual Dialysis Conference Michelle Hofmann RN, BSN, CNN Renal Clinical Educator - Home

Original Article. Introduction

Coming to a Home near You

Clinical judgment is the most important element in overhydration assessment of chronic hemodialysis patients

Intradialytic hypertension is a marker of volume excess

2015 Children's Mercy Hospitals and Clinics. All Rights Reserved.

Which dialysis unit blood pressure is the most accurate for predicting home blood pressure in patients undergoing hemodialysis?

Overcoming the Cardiorenal Syndrome

Fluid Management Workbook

All patients suitable for home dialysis should do PD first

End-Stage Renal Disease. Anna Vinnikova, M.D. Associate Professor of Medicine Division of Nephrology

The comparative evaluation of patients body dry weight under hemodialysis using two methods: Bioelectrical impedance analysis and conventional method

HYPERTENSION AND HEART FAILURE

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

Blood Pressure Monitoring in Chronic Kidney Disease

HYPERTENSION: UPDATE 2018

Ultrafiltration Programs : Clinical Experiences

Predicting and changing the future for people with CKD

Las dos caras de la cretinina sérica The two sides of serum creatinine

Acute Kidney Injury. Elaine Go, RN, MSN, CNN-NP. Clinical Educator, St. Joseph Hospital Renal Center Nurse Practitioner NSMG Orange, Ca

Hemodialysis Research Update: A Summary of Current Projects and What Lies Ahead

Weight Training. How do we get stronger?

The Association between Hypoalbuminemia and Intradialytic Hypotension in Heamodialysis Patients

The relationship between symptoms and blood pressure during maintenance hemodialysis

Clinical praxis for assessment of dry weight in Sweden and Denmark: A mixed-methods study

As you have a degree of basic fitness and confidence, 3 months or so of training should prepare you for your challenge.

USRDS UNITED STATES RENAL DATA SYSTEM

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Characteristics of hypotension-prone haemodialysis patients: is there a critical relative blood volume?

Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial

Trial to Reduce. Aranesp* Therapy. Cardiovascular Events with

Nephrology Dialysis Transplantation

Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line

Nutritional Cases with CKD HEMODIALYSIS

Dialysate sodium, serum sodium and mortality in maintenance hemodialysis

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

Recognizing and Treating Patients with the Cardio-Renal Syndrome

ASN DIALYSIS ADVISORY GROUP ASN DIALYSIS CURRICULUM

Hypotension During Haemodialysis: Aetiology, Risk Factors and Outcome

PREVALENCE AND TYPES OF INTRA-DIALYTIC COMPLICATIONS IN PATIENTS DIALYSING AT THE UNIVERSITY OF BENIN TEACHING HOSPITAL

ASN respectfully requests that CGS Administrators revise the LCD to:

St George Hospital Renal Department: INTERNAL ONLY

Clinical Evaluation of an Oscillometric NIBP Technology During Hemodialysis According to the British Hypertension Society Protocol

The Intact Nephron Hypothesis in Reverse: An Argument In Favor of Incremental Initiation Of Dialysis (With Residual Kidney Function)

What is hypertension?

CHILD WATCH SUN MON TUES WED THURS FRI SAT SCHEDULE: Child Watch Reminders: 9AM-4PM 5:30 PM - 9:30 PM

Hypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic

ATHLETE START UP QUESTIONNAIRE The first step in the coaching process is filling out the athlete questionnaire. Once completed, back to me.

Cardiac Rehabilitation & Exercise Training in Congenital Heart Disease. Jidong Sung Division of Cardiology Sungkyunkwan University School of Medicine

Disclosure. No relevant financial relationships. Placebo-Controlled Statin Trials

Transcription:

Not Too fast, Not Too Slow: Striking the Optimal Balance in Hemodialysis Fluid Management ANNA/ IPRO Spring Symposium May 24, 2018 Jennifer E. Flythe, MD, MPH Assistant Professor of Medicine University of North Carolina Kidney Center

Disclosures Funding: NIH/ NIDDK, PCORI, Robert Wood Johnson Foundation, and Renal Research Institute (a subsidiary of Fresenius Medical Care) Speaking Honorarium: Dialysis Clinic, Inc., Fresenius Medical Care, Renal Ventures, American Renal Associates, American Society of Nephrology, Baxter, multiple universities

Outline Fluid management: the conundrum Ultrafiltration rate and outcomes Extracellular volume overload and outcomes Clinical cases and management strategies

Fluid management: the conundrum

Call for Volume First Approach Good fluid management identified as one of the most essential unmet needs of the contemporary dialysis population. Weiner. Am J Kid Dis, 2014.

Extracellular volume Fluid removal rate Interdialytic weight gain

Hypovolemia Hypervolemia Overly rapid ultrafiltration rate Overly slow ultrafiltration rate Hemodynamic instability End-organ ischemia Patient discomfort Hypertension Ventricular hypertrophy Heart failure, arrhythmia Patient discomfort

Hypovolemia Hypervolemia Overly rapid ultrafiltration rate Overly slow ultrafiltration rate

They said [cramps] are close to what a man feels like having a baby. If that s the way it is, boy, I wouldn t want to have one. [60y M] It feels terrible because sometimes I'll be gasping for breath. I start crying because I can't breathe. It's like my own lungs is shutting down and I just can't get the breath that I need. [49y F] As soon as the cramps start, I m yelling. You never die, but it s so painful that you think that you do. [55y F] I just kind of panic when I can t get a deep breath. It s like I feel like I m going to smother. [76y F] Flythe. Neph Dialysis Trans, 2018.

Ultrafiltration rate and outcomes

Ultrafiltration rate UF rate (ml/h/kg) = IDWG (ml) TT (h) Post-weight (kg) UF = ultrafiltration IDWG = interdialytic weight gain TT= treatment time (dialysis session length)

1 1.2 1.4 1.6 1.8 2 Higher UF rate death lkjlk Associations between UFR and CV and all-cause mortality UF rate 13 ml/h/kg CV mortality All-cause mortality Flythe. Kid Int, 2011. 5 10 15 20 UFR (ml/hr/kg)

Higher UF rate death U.S. cohort (N=118,394) UF rate (ml/h/kg) All-cause mortality Adjusted HR (95% CI) >10 (vs. 10) 1.22 (1.20-1.24) >13 (vs. 13) 1.31 (1.28-1.34) Consistent across sex, race, ethnicity, vintage, and treatment time Consistent when considered relative to weight (kg), BMI (kg/m 2 ), and BSA (m 2 ) Assimon/ Flythe. Am J Kid Dis, 2016.

Higher UF rate death U.S. cohort (N=118,394) UF rate (ml/h/kg) All-cause mortality Adjusted HR (95% CI) <6 1.00 (reference) 6-8 1.03 (1.00-1.07) 8-10 1.09 (1.06-1.12) 10-12 1.15 (1.12-1.19) 12-14 1.22 (1.18-1.27) >14 1.43 (1.39-1.48) Assimon/ Flythe. Am J Kid Dis, 2016.

Higher UF rate longer recovery time U.S. cohort (N=2,689) Hussein. Am J Neph, 2017.

UF rate > plasma refill rate hypotension Ultrafiltration Vascular space Vascular space Plasma refill Interstitial space

Intradialytic hypotension (IDH) death N=39,497 incident HD patients (U.S.) (+) IDH in >10% tmts Adjusted HR (95% CI) All-cause mortality 1.19 (1.06 1.34) Cardiovascular (CV) mortality 1.22 (1.02 1.48) Fluid overload hospitalization 1.22 (1.11 1.34) Major CV event 1.29 (1.19 1.40) Stefansson. Clin J Am Soc Neph, 2014.

Intradialytic hypotension (IDH) death IDH: Nadir systolic BP <90 mmhg in >30% of treatments Prevalent HD patients IDH (vs. no IDH) Adjusted OR (95% CI) Dialysis Org. Cohort (N=10,392) 1.30 (1.07 1.57) HEMO Study cohort (N=1,753) 1.38 (1.11 1.71) Flythe. J Am Soc Neph, 2014.

Weight Gain Ultrafiltration Rate Treatment Time Hypotension Procedural modifications Hypo-perfusion of other vascular beds Myocardial Stunning Hypervolemia Cardiac Structural Change Morbidity and Mortality Assimon/ Flythe. Curr Opin Neph HTN, 2015.

UF rate IDH cardiac stunning death McIntyre. Clin J Am Soc Neph, 2008 and Burton. Clin J Am Soc Neph, 2009.

Higher UF rate other organ stunning death Brain Kidney Liver Gut Eldehni. Clin J Am Soc Neph, 2015, McIntyre. Clin J Am Soc Neph, 2011 and McIntyre. ASN abstracts, 2016.

2018 Core Survey Data Worksheet Clinical Quality Indicator Average UF rate >13 ml/h/kg U.S. threshold: 10.1% 2020 ESRD QIP Reporting Measure UF Rate Measure % of patients in the facility with average UF rate 13 ml/h/kg

UF rate mitigation Weight gain UF volume UF rate (ml/h/kg) = IDWG (ml) TT (h) Post-weight (kg) UF = ultrafiltration IDWG = interdialytic weight gain TT= treatment time Extend dialysis time

Treatment time: patient preferences 15m TT extension 44.6% 30m TT extension 21.3% 45m TT extension 9.7% 4th treatment 12.2% Flythe. Clin J Am Soc Neph, 2016.

Mean additional TT (h/week) Treatment time: clinic operational burden 100 98 80 60 53 40 20 12 26 0 <=25 26-50 51-100 >100 Flythe. Clin J Am Soc Neph, 2016. Facility size (patients)

IDWG reduction via fluid restriction Fluid restrictions: poor adherence: Surveyed 437 patients with fluid restrictions >40% adhered to prescribed fluid restriction <1 day/ week Virtually impossible (and inhumane) in over-salted individuals Flythe. Clin J Am Soc Neph, 2014.

Extracellular volume overload and outcomes

Goal = extracellular euvolemia Incorrect target weight (i.e. wrong dry weight) Failure to achieve target weight

Target weight estimation in practice Tools Blood volume monitor Bioimpedance Biomarkers

Extracellular volume overload (BVM) death U.S. cohort (N=308) Agarwal. Hypertension, 2010. Adapted from R. Agarwal with permission.

Extracellular volume overload death 26 country cohort Volume status by multi-frequency bioimpedance Baseline fluid overload N=39,566 1-year cumulative fluid overload N=22,845 Zoccali. J Am Soc Neph, 2017.

Post-dialysis weight > target weight death Italian cohort (N=182) Movilli. Am J Neph, 2013.

A d j u s t e d R D ( 9 5 % C I ) Post-dialysis weight > target weight 30-day death U.S. cohort (N=113,561) 0. 5 % 0. 3 5 % ( 0. 2 9 %, 0. 4 1 % ) 0. 4 % 0. 3 % 0. 1 8 % ( 0. 1 1 %, 0. 2 5 % ) 0. 2 % 0. 1 1 % ( 0. 0 6 %, 0. 1 6 % ) 0. 1 % 0. 0 % 0. 0 0 % ( r e f. ) - 0. 1 % < 5 % 5-2 9 % 3 0-4 9 % 5 0 % Assimon and Flythe. J Am Soc Nephrol, 2018. % o f e x p o s u r e p e r i o d t r e a t m e n t s w i t h p o s t - d i a l y s i s w e i g h t > 1. 0 k g a b o v e t a r g e t w e i g h t

Extracellular volume overload fatigue 110 hemodialysis patients with multi-frequency biompendance Multivariable linear regression model (adjusted R 2 = 0.41) Multi-dimensional fatigue inventory score β (p-value) Beck Depression Inventory 20.8 (<0.001) Recovery time >8h 11.4 (0.001) Post-HD %ECW/TBW 2.9 (0.002) Muscle wasting -5.7 (0.05) Tangvoraphonkchai. Ther Apher Dial, 2018.

UF rate minimization without volume expansion

Fluid management cases

Clinical Case 1 55y man Diabetes, heart failure (EF 45%, history of hospitalizations) Myasthenia gravis on bimonthly plasmapheresis Hemodialysis IDWG = 3-4.5 kg TT = 3.5 hours T-R-Sat Target weight = 73 kg Post-weights = ~73 kg Anuric Mean pre-hd systolic BP 110s ekt/v = 1.6 UF rate = 11.7 17.6 ml/h/kg Weekly mean UF rate = 14.6 ml/h/kg Asymptomatic hypotension

13 (ml/h/kg) = UF rate IDWG (kg) TT (h) 73 (kg) Post-weight

Tuesday 4 h treatment weekend IDWG goal = <3.8 kg 1.3 L/day w 72 h break ~13 ml/h/kg Thursday and Saturday 3.25 h treatment IDWG goal = <3 kg 1.5 L/day w 48 h break ~12.6 ml/h/kg 10.5 h/week treatment Actual mean UF rate = 12 ml/h/kg

Strategies Case 1: Longer treatments after the long interdialytic break

49y man with hypertension Clinical Case 2 Hemodialysis Typical IDWG = 1 2 kg TT = 3h M-W-F Target weight = 51.5 kg But one Monday, IDWG: 4 kg UF rate = 6.5-12.9 ml/h/kg UF rate = 25.9 ml/h/kg

Take the long view Sun Mon Tues Wed Thurs Fri Sat Goal: target weight achievement by the end of the week

Case: Finding the balance TT Target wt IDWG Pre-wt UF volume UF rate Post-wt Monday Wednesday Friday 3 h 51.5 kg 4 kg 55.5 2.5 L 16.2 ml/h/kg 53 kg 3 h 51.5 kg 1 kg 54 kg 2 L 12.9 ml/h/kg 52 kg 3 h 51.5 kg 1 kg 53 kg 1.5 L 9.7 ml/h/kg 51.5 kg Success contingent on controlled IDWG for remainder of week

Strategies Case 1: Longer treatments after the long interdialytic break Case 2: Balance UF rate and fluid overload-related harms

Clinical Case 3 48y woman with vascular disease s/p L BKA, heart failure (EF 40%) Hemodialysis Typical IDWG = 2.5 3 kg TT = 3.5h T-R-Sat Target weight = 82.0 kg Pre-HD SBP: 90s (nadir ~80 mmhg) Leg cramping ¾ way through treatment UF rate = 8.7-10.4 ml/h/kg Hypotension Cramping

Identify and align goals Medical Goals Minimize cardiovascular risk Avoid hypotension Prevent cramping Patient Goals Spend time with family Pain-free dialysis Cramping Post-dialysis fatigue Goal-directed Dialysis TT to 4 hours for 4 weeks Follow symptoms weekly (cramping, recovery time) (+) Patient-perceived improvement: maintain TT (-) Patient-perceived improvement: return to prior TT

Strategies Case 1: Longer treatments after the long interdialytic break Case 2: Balance UF rate and fluid overload-related harms Case 3: Time-limited, symptom-guided trials (connect to patient goals)

Clinical Case 4 66y man with heart failure (EF 25%) with frequent hospitalizations Hemodialysis Typical IDWG = 3 3.5 kg TT = 4h M-W-F Target weight = 70 kg Post-HD weights (last 4 treatments) Mon: 73 kg Wed: 72 kg Fri: 71.5 kg Mon: 72 kg UF rate = 10.7-12.5 ml/h/kg Failure to achieve target wt

Target weight prescription and readmissions N= 44,460 patients with hospitalizations Exposure: target weight adjustment (vs. not) within 7 days of hospital discharge # needed to treat 114 ED visit* 61 Readmission* 49 Composite outcome* * 30-day outcomes Assimon and Flythe. J Am Soc Nephrol, 2018.

Target weight achievement vigilance Identify target weight achievement problem Assess reasons (hemodynamics, symptoms, other) Target weight adjustment? (exam, history, treatment tolerance and history) Additional treatment? Treatment time adjustment? Other Take action Root cause: single episode of large IDWG 10 days ago Solution: add single extra treatment (2h) to return to target weight

Strategies Case 1: Longer treatments after the long interdialytic break Case 2: Balance UF rate and fluid overload-related harms Case 3: Time-limited, symptom guided trials Case 4: Target weight achievement vigilance and extra treatment

Clinical practice suggestions Case 1: Longer treatments after the long interdialytic break Case 2: Balance UF rate and fluid overload-related harms Case 3: Time-limited, symptom guided trials Case 4: Target weight achievement vigilance and extra treatment Lower interdialytic weight gain through a focus on sodium In-center nocturnal hemodialysis Send patients home Ultrafiltration profiling? Strategy must be individualized and take into account patient preferences and treatment goals

Summary Higher UF rates are associated with adverse outcomes. Extracellular volume expansion is associated with adverse outcomes. Euvolemia achievement and UF rate minimization are both important. Their relative importance is unknown. Fluid management plans should be individualized based on patient risk profiles, preferences and, possibly, symptoms.

Feedback requested: Research Readiness Toolkit Discussion Guide 1. WATCH video 2. REVIEW materials 3. TALK discussion questions 4. RECORD research preferences Video Lunch & Learn Module Written Materials Julia Narendra UNC Dialysis Research Team

Questions?